April 13, 2024Open Access

Psychotropic Medication Use and Polypharmacy Among Children and Adolescents Initiating Intensive Behavioral Therapy for Severe Challenging Behavior

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

To evaluate the prevalence, trends, and factors associated with psychotropic medication use and polypharmacy among children and adolescents initiating intensive behavioral therapy for severe challenging behavior over a 10-year period.

Preguntar a la IA

Me gusta

Guardar

Ver artículo completo

Cite This Study

O’Brien et al. (Sat,) studied this question.

synapsesocial.com/papers/68e6f4b7b6db64358766f2a1 https://doi.org/https://doi.org/10.1016/j.jpeds.2024.114056

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Side Effects from Use of One or More Psychiatric Medications in a Population-Based Sample of Children and Adolescents2014 · 60 citations
2Psychotropic Practice Patterns for Youth2003 · 529 citations
3Long-Term, Open-Label Study of Risperidone in Children With Severe Disruptive Behaviors and Below-Average IQ2004 · 164 citations
4Multimodal Treatment of ADHD in the MTA: An Alternative Outcome Analysis2001 · 289 citations
5A Pilot Study of Risperidone, Olanzapine, and Haloperidol in Psychotic Youth: A Double-Blind, Randomized, 8-Week Trial2003 · 308 citations

Preguntar a la IA

Me gusta

Guardar

Ver artículo completo